{
    "2018-07-22": [
        [
            {
                "time": "",
                "original_text": "疫苗女商人高俊芳的财技",
                "features": {
                    "keywords": [
                        "疫苗",
                        "高俊芳",
                        "财技"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "长生生物私有化涉嫌侵占国资：涉长春高新和亚泰集团",
                "features": {
                    "keywords": [
                        "长生生物",
                        "私有化",
                        "国资",
                        "长春高新",
                        "亚泰集团"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "国企改革"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【华泰策略】弱市中喝酒吃药， 创业板延续加仓——2018 年二季度基金中报分析",
                "features": {
                    "keywords": [
                        "华泰策略",
                        "弱市",
                        "喝酒吃药",
                        "创业板",
                        "基金中报",
                        "2018年二季度"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "医药",
                        "创业板"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "长春长生“狂苗”之路：工艺、渠道和资本的十年博弈",
                "features": {
                    "keywords": [
                        "长春长生",
                        "狂苗",
                        "工艺",
                        "渠道",
                        "资本",
                        "十年博弈"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}